Karyopharm Therapeutics (KPTI) EPS (Diluted) (2020 - 2026)
Karyopharm Therapeutics (KPTI) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.15 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Karyopharm Therapeutics | 53.25 Mn | 53.25 Mn | 32.35 Mn | -2.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.13 |
| Dec 31, 2025 | 12,015.27 |
| Sep 30, 2025 | -3,821.32 |
| Jun 30, 2025 | -4,321.58 |
| Mar 31, 2025 | -2,770.01 |
| Dec 31, 2024 | 5,401.59 |
| Sep 30, 2024 | -3,848.33 |
| Jun 30, 2024 | 2.31 |
| Mar 31, 2024 | -4.85 |
| Dec 31, 2023 | 13.29 |
| Sep 30, 2023 | -4.52 |
| Jun 30, 2023 | -4.29 |
| Mar 31, 2023 | -4.51 |
| Dec 31, 2022 | -7.22 |
| Sep 30, 2022 | -6.79 |
| Jun 30, 2022 | -9.24 |
| Mar 31, 2022 | -8.01 |
| Dec 31, 2021 | 7.72 |
| Sep 30, 2021 | -10.30 |
| Jun 30, 2021 | -10.69 |